| Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial L Guglielmetti, E Ardizzoni, M Atger, E Baudin, E Berikova, M Bonnet, ... Trials 22, 1-15, 2021 | 32 | 2021 |
| Clinical outcomes of individuals with COVID-19 and tuberculosis during the pre-vaccination period of the pandemic: A systematic review TA Jhaveri, C Fung, AN LaHood, A Lindeborg, C Zeng, R Rahman, ... Journal of Clinical Medicine 11 (19), 5656, 2022 | 11 | 2022 |
| Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications ML Rich, U Khan, C Zeng, A LaHood, MF Franke, S Atwood, M Bastard, ... The International Journal of Tuberculosis and Lung Disease 27 (6), 451-457, 2023 | 9 | 2023 |
| Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different A LaHood, R Rahman, L McKenna, M Frick, CD Mitnick Plos one 17 (7), e0271102, 2022 | 6 | 2022 |
| TB research requires strong protections, innovation, and increased funding in response to COVID-19 BT Nyang’wa, AN LaHood, CD Mitnick, L Guglielmetti Trials 22 (1), 371, 2021 | 5 | 2021 |
| Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country … SB Patil, M Tamirat, K Khazhidinov, E Ardizzoni, M Atger, A Austin, ... Trials 24 (1), 773, 2023 | 2 | 2023 |
| Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin-or Multidrug-Resistant Tuberculosis in Kazakhstan M Rashitov, MF Franke, L Trevisi, G Bekbolatova, J Shalimova, ... Clinical Infectious Diseases 79 (4), 1046-1053, 2024 | 1 | 2024 |
| “I have to breathe”: A mixed-methods pilot study to assess the feasibility, acceptability, cost, and effectiveness of an intervention for post-tuberculosis lung disease C Almeida, R Durand, A LaHood, A Byrne, A Mendoza-Ticona, E Ygnacio, ... | | 2024 |
| †œI have to breatheâ€: A Mixed-Methods Pilot Study to Assess the Feasibility, Acceptability, Cost, and Effectiveness of an Intervention for Post-Tuberculosis Lung Disease CPB Almeida, RA Durand, AN LaHood, AL Byrne, A Mendoza-Ticona, ... Global Journal of Health Science 16 (8), 48-69, 2024 | | 2024 |
| Respiratory, Cardiac, and Neuropsychiatric Manifestations of Postacute Sequelae of Coronavirus Disease 2019 in Lima, Peru RS Rahman, MA Tovar, J Peinado, JS Palomino, C Ramirez, ... Open Forum Infectious Diseases 10 (7), ofad320, 2023 | | 2023 |
| MAJOR ARTICLE RS Rahman, MA Tovar, J Peinado, JS Palomino, C Ramirez, ... | | 2023 |
| Uniting Infection Biology for One Health PML Atienza, J Harless, K Hassevoort, R Holland, MB Kuyumjian, ... Illinois 150: The 21st Century Research University and the Public Good, 2019 | | 2019 |
